IP Verse

Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist

Patent No. EP3973987 (titled "Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist") was filed by Regeneron Pharmaceuticals on Feb 20, 2015. The application was issued on Jan 10, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTOct 10, 2024BOULT WADE TENNANT
HAMPTON KNOWLESOct 10, 2024D YOUNG
LUIGIOct 10, 2024TER MEER STEINMEISTER & PARTNER
MICHALSKI HUTTERAMNN & PARTNER PATENTANWALTE MBBOct 10, 2024-
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBOct 10, 2024-
SECERNAOct 9, 2024SECERNA
DR H ULRICH DORRIESOct 1, 2024DORRIES
DR H ULRICH DORRIESOct 1, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3973987

REGENERON PHARMACEUTICALS
Application Number
EP21191120A
Filing Date
Feb 20, 2015
Status
Granted And Under Opposition
Dec 8, 2023
Publication Date
Jan 10, 2024
External Links
Slate, Register , Google Patents